Jiangsu CoWin Biotech Statistics

Total Valuation

SHA:688426 has a market cap or net worth of CNY 2.09 billion. The enterprise value is 1.47 billion.

Market Cap	2.09B
Enterprise Value	1.47B

Important Dates

The last earnings date was Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

SHA:688426 has 111.14 million shares outstanding. The number of shares has decreased by -1.13% in one year.

Current Share Class	n/a
Shares Outstanding	111.14M
Shares Change (YoY)	-1.13%
Shares Change (QoQ)	+1.23%
Owned by Insiders (%)	0.16%
Owned by Institutions (%)	13.36%
Float	36.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.60
PB Ratio	1.41
P/TBV Ratio	1.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.32
EV / Sales	11.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.06

Financial Position

The company has a current ratio of 9.92, with a Debt / Equity ratio of 0.02.

Current Ratio	9.92
Quick Ratio	8.55
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.17
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -10.19% and return on invested capital (ROIC) is -6.04%.

Return on Equity (ROE)	-10.19%
Return on Assets (ROA)	-5.67%
Return on Invested Capital (ROIC)	-6.04%
Return on Capital Employed (ROCE)	-10.17%
Revenue Per Employee	191,591
Profits Per Employee	-239,283
Employee Count	657
Asset Turnover	0.07
Inventory Turnover	1.42

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.96% in the last 52 weeks. The beta is 0.67, so SHA:688426's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	-5.96%
50-Day Moving Average	20.56
200-Day Moving Average	21.57
Relative Strength Index (RSI)	51.31
Average Volume (20 Days)	946,849

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688426 had revenue of CNY 125.88 million and -157.21 million in losses. Loss per share was -1.41.

Revenue	125.88M
Gross Profit	70.40M
Operating Income	-156.00M
Pretax Income	-164.70M
Net Income	-157.21M
EBITDA	-127.33M
EBIT	-156.00M
Loss Per Share	-1.41

Full Income Statement

Balance Sheet

The company has 672.51 million in cash and 27.84 million in debt, giving a net cash position of 644.67 million or 5.80 per share.

Cash & Cash Equivalents	672.51M
Total Debt	27.84M
Net Cash	644.67M
Net Cash Per Share	5.80
Equity (Book Value)	1.49B
Book Value Per Share	13.20
Working Capital	749.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -113.26 million and capital expenditures -48.41 million, giving a free cash flow of -161.67 million.

Operating Cash Flow	-113.26M
Capital Expenditures	-48.41M
Free Cash Flow	-161.67M
FCF Per Share	-1.45

Full Cash Flow Statement

Margins

Gross margin is 55.93%, with operating and profit margins of -123.93% and -124.89%.

Gross Margin	55.93%
Operating Margin	-123.93%
Pretax Margin	-130.85%
Profit Margin	-124.89%
EBITDA Margin	-101.16%
EBIT Margin	-123.93%
FCF Margin	n/a

Dividends & Yields

SHA:688426 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.13%
Shareholder Yield	1.13%
Earnings Yield	-7.52%
FCF Yield	-7.74%

Dividend Details

Stock Splits

The last stock split was on June 12, 2023. It was a forward split with a ratio of 1.2000048.

Last Split Date	Jun 12, 2023
Split Type	Forward
Split Ratio	1.2000048

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a